Showing results (91-100 of 124) with videos related to
Sort By:
Pageof 13
Hepato-Gastroenterology|August 12, 2011
Co-existence of gastrointestinal stromal tumors with other primary neoplasmsAlper Sevinc, Mesut Seker, Ahmet Bilici, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 25, 2012
Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcomaAli Osman Kaya, Süleyman Büyükberber, Metin Ozkan, et al.Medical Oncology (Northwood, London, England)|February 27, 2009
Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancerAli Osman Kaya, Suleyman Buyukberber, Mustafa Benekli, et al.Asian Pacific Journal of Cancer Prevention : APJCP|May 28, 2009
Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancerAziz Karaoglu, Ulku Yalcintas Arslan, Metin Ozkan, et al.Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerMeltem Baykara, Ugur Coskun, Veli Berk, et al.Journal of the National Medical Association|September 1, 2009
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancerUgur Coskun, Necati Alkis, Gokhan Celenkoglu, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 17, 2009
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimensRamazan Yildiz, Mehmet Emin Kalender, Faysal Dane, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 12, 2020
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre studyZeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2020
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational studyMustafa Benekli, Mahmut Gumus, Metin Ozkan, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 2, 2019
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre studyZeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, et al.Pageof 13